Siemens Healthineers AG (OTCMKTS:SMMNY) Stock Short Interest Report for October

Siemens Healthineers AG (OTCMKTS:SMMNY) was the recipient of a large decline in short interest in the month of October. As of October 30th, there was short interest totaling 7,112 shares, a decline of 89.8% from the October 15th total of 69,756 shares. Based on an average daily trading volume, of 66,210 shares, the short-interest ratio is currently 0.1 days.

Siemens Healthineers Price Performance

SMMNY traded up $0.02 during trading hours on Thursday, hitting $24.19. 5,318 shares of the company’s stock were exchanged, compared to its average volume of 125,338. Siemens Healthineers has a 12-month low of $19.20 and a 12-month high of $27.46. The firm has a 50 day moving average of $22.67 and a 200 day moving average of $21.92.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on SMMNY shares. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Siemens Healthineers in a research report on Friday, October 16th. Zacks Research cut shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 1st. Deutsche Bank reissued a “hold” rating on shares of Siemens Healthineers in a research note on Tuesday, August 18th. Finally, Citigroup restated a “buy” rating on shares of Siemens Healthineers in a report on Tuesday, October 13th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy”.

About Siemens Healthineers

Siemens Healthineers AG is a Germany-based medical technology company that develops products, services and digital solutions for healthcare providers. Its portfolio supports diagnostic, therapeutic and monitoring activities across hospitals, clinics, laboratories and other healthcare settings. The company’s offerings include magnetic resonance imaging, computed tomography, X-ray, molecular imaging and ultrasound systems, as well as laboratory diagnostics, point-of-care testing and related software.